|
Name |
Methyl 15-methylhexadecanoate
|
Molecular Formula | C18H36O2 | |
IUPAC Name* |
methyl 15-methylhexadecanoate
|
|
SMILES |
CC(C)CCCCCCCCCCCCCC(=O)OC
|
|
InChI |
InChI=1S/C18H36O2/c1-17(2)15-13-11-9-7-5-4-6-8-10-12-14-16-18(19)20-3/h17H,4-16H2,1-3H3
|
|
InChIKey |
BNHKXOIJKIMOJH-UHFFFAOYSA-N
|
|
Synonyms |
Methyl 15-methylhexadecanoate; 6929-04-0; Methyl isoheptadecanoate; Hexadecanoic acid,15-methyl-, methyl ester; Hexadecanoic acid, 15-methyl-, methyl ester; 15-Methylhexadecanoic acid methyl ester; Methyl 15-methylpalmitate; SCHEMBL2254699; DTXSID10334924; ZINC4557090; Hexadecanoic acid,15-methyl-,methyl ester; FT-0731782; Q63392144; 021412EE-6DF4-4E02-A06D-81DAA198DFFD
|
|
CAS | 6929-04-0 | |
PubChem CID | 522345 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 284.5 | ALogp: | 8.2 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 15 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 20 | QED Weighted: | 0.29 |
Caco-2 Permeability: | -4.704 | MDCK Permeability: | 0.00001450 |
Pgp-inhibitor: | 0.043 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.959 |
30% Bioavailability (F30%): | 0.983 |
Blood-Brain-Barrier Penetration (BBB): | 0.293 | Plasma Protein Binding (PPB): | 97.17% |
Volume Distribution (VD): | 1.909 | Fu: | 1.73% |
CYP1A2-inhibitor: | 0.331 | CYP1A2-substrate: | 0.201 |
CYP2C19-inhibitor: | 0.458 | CYP2C19-substrate: | 0.166 |
CYP2C9-inhibitor: | 0.289 | CYP2C9-substrate: | 0.967 |
CYP2D6-inhibitor: | 0.053 | CYP2D6-substrate: | 0.034 |
CYP3A4-inhibitor: | 0.345 | CYP3A4-substrate: | 0.085 |
Clearance (CL): | 5.359 | Half-life (T1/2): | 0.217 |
hERG Blockers: | 0.146 | Human Hepatotoxicity (H-HT): | 0.033 |
Drug-inuced Liver Injury (DILI): | 0.395 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.023 | Maximum Recommended Daily Dose: | 0.014 |
Skin Sensitization: | 0.953 | Carcinogencity: | 0.06 |
Eye Corrosion: | 0.942 | Eye Irritation: | 0.964 |
Respiratory Toxicity: | 0.883 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000848 | 0.949 | D07ILQ | 0.506 | ||||
ENC000548 | 0.946 | D0Z5SM | 0.486 | ||||
ENC001519 | 0.893 | D0P1RL | 0.443 | ||||
ENC001181 | 0.862 | D05ATI | 0.411 | ||||
ENC001142 | 0.806 | D00FGR | 0.409 | ||||
ENC000560 | 0.783 | D0O1PH | 0.402 | ||||
ENC000271 | 0.746 | D0T9TJ | 0.400 | ||||
ENC000604 | 0.733 | D0G2KD | 0.388 | ||||
ENC001274 | 0.732 | D00AOJ | 0.382 | ||||
ENC000496 | 0.712 | D00MLW | 0.359 |